Publications by authors named "Pete Anderson"

Claim this Profile
T
The response of coarse root biomass to long-term CO enrichment and nitrogen application in a maturing Pinus taeda stand with a large broadleaved component.
Chris A Maier, Kurt H Johnsen, Pete H Anderson, Sari Palmroth, Dohyoung Kim

Glob Chang Biol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-sodium fluoride positron emission tomography (NaF-18-PET/CT) radiomic signatures to evaluate responses to alpha-particle Radium-223 dichloride therapy in osteosarcoma metastases.
Kalevi Kairemo, Jason Roszik, Pete Anderson, Gregory Ravizzini, Arvind Rao

Curr Probl Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention.
Paul K Drain, Ashley R Bardon, Jane M Simoni, Tim R Cressey, Pete Anderson

Curr HIV/AIDS Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy.
Pete M Anderson, Jacob Scott, Shireen Parsai, Stacey Zahler, Sarah Worley

ESMO Open· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial.
Vivek Subbiah, Pete M Anderson, Kalevi Kairemo, Kenneth Hess, Winston W Huh

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women.
Maria Pyra, Pete Anderson, Jessica E Haberer, Renee Heffron, Connie Celum

Front Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST.
Kalevi Kairemo, Eric M Rohren, Pete M Anderson, Gregory Ravizzini, Arvind Rao

ESMO Open· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival.
Vivek Subbiah, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, Brian A Menegaz, Pamela Camacho, Pete M Anderson

Clin Cancer Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecosystem carbon density and allocation across a chronosequence of longleaf pine forests.
Lisa J Samuelson, Thomas A Stokes, John R Butnor, Kurt H Johnsen, Carlos A Gonzalez-Benecke, Pete H Anderson

Ecol Appl· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
J Andrew Livingston, Kenneth R Hess, Aung Naing, David S Hong, Shreyaskumar Patel, Pete Anderson

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors.
Yunyun Jiang, Vivek Subbiah, Filip Janku, Joseph A Ludwig, Aung Naing, Pete Anderson

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Vivek Subbiah, Michael J Wagner, Mary F McGuire, Nawid M Sarwari, Eswaran Devarajan, Pete Anderson

Oncotarget· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.
Vivek Subbiah, Manojkumar Bupathi, Shumei Kato, Andrew Livingston, John Slopis, Pete M Anderson

Oncoscience· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha Emitter Radium 223 in High-Risk Osteosarcoma: First Clinical Evidence of Response and Blood-Brain Barrier Penetration.
Vivek Subbiah, Pete Anderson, Eric Rohren

JAMA Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience.
Fernando F Corrales-Medina, Cynthia Herzog, Kenneth Hess, Daniela Egas-Bejar, David S Hong, Pete Anderson

Oncoscience· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostic Profiling for Actionable Aberrations in Advanced High Risk Osteosarcoma with Aggressive Biology Reveals High Molecular Diversity: The Human Fingerprint Hypothesis.
Daniela Egas-Bejar, Pete M Anderson, Rishi Agarwal, Fernando Corrales-Medina, Eswaran Devarajan

Oncoscience· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).
Vivek Subbiah, Robert E Brown, Yunyun Jiang, Jamie Buryanek, Andrea Hayes-Jordan, Pete M Anderson

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
Montserrat Ayala-Ramirez, Cecile N Chougnet, Mouhammed Amir Habra, J Lynn Palmer, Sophie Leboulleux, Pete Anderson

J Clin Endocrinol Metab· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors.
Aung Naing, Patricia LoRusso, Siqing Fu, David S Hong, Pete Anderson

Clin Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapy of Ewing's Sarcoma.
Vivek Subbiah, Pete Anderson

Sarcoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases.
Vivek Subbiah, Ravi Murthy, Pete M Anderson

J Clin Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.
Vivek Subbiah, Aung Naing, Robert E Brown, Helen Chen, Laurence Doyle, Pete Anderson

PLoS One· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tactical combat casualty care February 2010. Direct from the Battlefield: TCCC lessons learned in Iraq and Afghanistan.
Virgil T Deal, Douglas McDowell, Peter Benson, Bart Iddins, Gary Gluck, Pete Anderson

J Spec Oper Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting and facilitating survival of pediatric cancer patients: the ALC story.
Pete Anderson

Pediatr Blood Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can anthracycline therapy for pediatric malignancies be less cardiotoxic?
Joy M Fulbright, Winston Huh, Pete Anderson, Joya Chandra

Curr Oncol Rep· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis